FSTL1 mRNA expression could be restored after treatment with 5-aza-dC (Figure 1B), which suggests that promoter hypermethylation might contribute to the inactivation of FSTL1 in NPC cells. The gene discussed is FSTL1; the disease is nasopharyngeal carcinoma.